Glenmark Pharmaceuticals Inc., USA, is voluntarily recalling 144 batches of potassium chloride extended-release capsules because of failed dissolution, the FDA said June 25.
The medication is used for patients with low potassium. Failed dissolution can cause irregular heart beat, cardiac arrest, severe muscle weakness and death, according to the FDA. The company has not received any patient safety reports related to the recall.
The New Jersey-based drugmaker is alerting its wholesale and distributor customers about the recall.